Have we tipped the pendulum too far in favor of generics? On March 25, the Supreme Court heard oral argument in a closely watched case, FTC v. Actavis, Inc. The case involves a branded drug company’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback